News

Q1 2026 Publications from our Innovation Ecosystem

In the first quarter of 2026, researchers across the Target ALS innovation ecosystem published more than 30 peer-reviewed papers, spanning biomarkers, disease m…

Q1 2026 Grants & Funding Opportunities Update

Accelerating Progress Together: Target ALS’s Role in AMP® ALS 

A New Clue to One of the Most Common Genetic Causes of ALS and FTD

Target ALS Grantee NRG Therapeutics Advances NRG5051 into Phase I Clinical Trial

Target ALS Research Cores: Empowering Global ALS Discovery

Driving Breakthroughs: Target ALS Grants Empower the Next Wave of ALS Research

Harnessing the Power of Open Data: How the Target ALS Data Engine Accelerates Discovery for Global Scientists

Springboard Fellows: The Next Wave of ALS and FTD Scientists

Caring for Every Drop: Behind the Scenes with Lizzi Neylon